Interesting ImagesFDG PET/CT Imaging of Pancreatic PlasmacytomaHuang, Wen-Shan BM*; Zheng, Yongjiang MD†; Chen, Jia-Wen BM*; Zhang, Gui-Xiong BM*; Xu, Jie-Hua MD, PhD*Author Information From the Departments of *Nuclear Medicine †Hematology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People's Republic of China. Received for publication February 1, 2020; revision accepted February 8, 2020. W.-S.H., Y.Z., and J.-W.C. contributed equally to this work. The work was performed in the third affiliated hospital of Sun Yat-Sen University, Guangzhou, People's Republic of China. Conflicts of interest and sources of funding: No potential conflicts of interest were disclosed. This project was sponsored by the Natural Science Foundation of Guangdong Province, China (2018A030313200), and Natural Science Foundation of China (81101866). Correspondence to: Jie-Hua Xu, MD, PhD, Department of Nuclear Medicine, The Third Affiliated Hospital of Sun Yat-Sen University, No. 600 Tianhe Road, Guangzhou 510630, People's Republic of China. E-mail: email@example.com; firstname.lastname@example.org. Online date: , 2020 Clinical Nuclear Medicine: June 2020 - Volume 45 - Issue 6 - p 489-491 doi: 10.1097/RLU.0000000000003019 Buy Metrics Abstract A 56-year-old man underwent 18F-FDG PET/CT to evaluate possible pancreatic cancer, which was revealed by CT. The images showed a solid lesion with peripherally increased FDG activity in the tail of the pancreas, as well as hypermetabolic lesions in the lumbar spine and rib. Pathological examination following lumbar biopsy demonstrated multiple myeloma. Five months after chemotherapy, follow-up FDG PET/CT showed cystic change in the pancreatic lesion without elevated metabolism. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.